Movement on legalizing cannabis inches ahead on a federal level -
Cannabis rescheduling hearings began on January 21, 2025, to evaluate moving cannabis from Schedule I to Schedule III of the Controlled Substances Act as...more
3/28/2025
/ Cannabis Products ,
Cannabis-Related Businesses (CRBs) ,
Congressional Investigations & Hearings ,
Controlled Substances Act ,
DEA ,
Decriminalization of Marijuana ,
Enforcement ,
Hemp ,
Licensing Rules ,
Marijuana ,
Marijuana Related Businesses ,
Medical Marijuana ,
Regulatory Agenda ,
THC
Historic DEA marijuana rescheduling hearing opens, paused until mid-January -
Historic hearings to reconsider marijuana's federal status will start mid-January, as announced by U.S. DEA Judge John Mulrooney II. The focus...more
12/20/2024
/ Administrative Hearings ,
Cannabis Products ,
Cannabis-Related Businesses (CRBs) ,
DEA ,
Food and Drug Administration (FDA) ,
Hemp ,
Marijuana ,
Marijuana Related Businesses ,
NIST ,
Proposed Legislation ,
Regulatory Agenda
There Has Been Little Movement in Federal Legalization. This has led to cannabis investors and companies to downgrade expectations for federal legalization and focus their strategies on state reform.
Federal lawmakers...more
7/27/2023
/ Banking Sector ,
Banks ,
Biden Administration ,
Cannabidiol (CBD) oil ,
Cannabis Products ,
Cannabis-Related Businesses (CRBs) ,
Cole Memorandum ,
Congressional Investigations & Hearings ,
DEA ,
Decriminalization of Marijuana ,
Department of Justice (DOJ) ,
Hemp ,
Hemp Related Businesses ,
Information Reports ,
Interstate Commerce ,
Marijuana ,
Marijuana Cultivation ,
Marijuana Related Businesses ,
Medical Marijuana ,
Proposed Legislation ,
Regulatory Agenda ,
State and Local Government ,
Tax Revenues ,
THC